Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fortress Biotech (FBIO) Depreciation Expense (2016 - 2018)

Historic Depreciation Expense for Fortress Biotech (FBIO) over the last 3 years, with Q3 2018 value amounting to $548000.0.

  • Fortress Biotech's Depreciation Expense rose 17400.0% to $548000.0 in Q3 2018 from the same period last year, while for Sep 2018 it was $1.3 million, marking a year-over-year increase of 5479.12%. This contributed to the annual value of $700000.0 for FY2017, which is 7500.0% up from last year.
  • Latest data reveals that Fortress Biotech reported Depreciation Expense of $548000.0 as of Q3 2018, which was up 17400.0% from $466000.0 recorded in Q2 2018.
  • In the past 5 years, Fortress Biotech's Depreciation Expense ranged from a high of $548000.0 in Q3 2018 and a low of -$119000.0 during Q4 2017
  • In the last 3 years, Fortress Biotech's Depreciation Expense had a median value of $180000.0 in 2017 and averaged $199636.4.
  • Examining YoY changes over the last 5 years, Fortress Biotech's Depreciation Expense showed a top increase of 675000.0% in 2017 and a maximum decrease of 17437.5% in 2017.
  • Fortress Biotech's Depreciation Expense (Quarter) stood at $160000.0 in 2016, then tumbled by 174.38% to -$119000.0 in 2017, then soared by 560.5% to $548000.0 in 2018.
  • Its Depreciation Expense stands at $548000.0 for Q3 2018, versus $466000.0 for Q2 2018 and $365000.0 for Q1 2018.